Search
for
Sort by
Research 271–300 of 287
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Acute and Chronic Telogen Effluvium
- Acute and Chronic Telogen Effluvium
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
- Symptom Trajectories and Long-Term Sequelae of COVID-19: A Matched Case–Control Study with Population-Based Controls
- Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case–Control Study
- A comprehensive review of etiology, pathophysiologyepidemiology, and management of hair loss and its correlation with COVID-19
- FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- Pica for Uncooked Basmati Rice in Two Women with Iron Deficiency and a Review of Ryzophagia
- Role of nutritional supplements in selected dermatological disorders: A review
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Androgen sensitivity gateway to COVID‐19 disease severity
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- The role of testosterone in SARS-CoV-2 infection
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Redefining hormone resistance in prostate cancer
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review